Three major U.S. drug companies reported solid first-quarter results despite a strong dollar, amid signs that their increasing investment in new cancer drugs will be a key driver of Big Pharma’s future growth.
from WSJ.com: US Business http://ift.tt/1bb96mK
via IFTTT
No comments:
Post a Comment